12 results match your criteria: "Mayo Clinic and Mayo Foundation Rochester[Affiliation]"
J Neuroophthalmol
December 2004
Department of Ophthalmology, Mayo Clinic and Mayo Foundation Rochester, Minnesota 55905, USA.
Diagn Mol Pathol
March 2004
Department of Laboratory Medicine and Pathology, Mayo Clinic and Mayo Foundation Rochester, MN 55905, USA.
Although recent studies have analyzed Hepatitis C (HCV) infections in liver tissue by in situ hybridization (ISH), many of these studies have been of limited diagnostic utility because of the low copy numbers of HCV in formalin-fixed paraffin-embedded (FFPE) tissue and failure to correlate the ISH analysis with other methods of detecting HCV. Thirty six cases of liver biopsies from patients with known HCV antibody status including 20 cases of serum HCV positive and 16 cases of serum HCV negative were analyzed. All cases showed histologic features suggestion of HCV infection.
View Article and Find Full Text PDFMuscle Nerve
November 2003
Department of Neurology, Mayo Clinic and Mayo Foundation Rochester, Minnesota, USA.
This multicenter, randomized, open-label clinical trial was conducted to determine whether the combined use of nicotine patch therapy and a nicotine nasal spray would improve smoking abstinence rates compared to either treatment alone, without behavioral counseling. Data were collected at 15 regional cancer control oncology centers within the North Central Cancer Treatment Group. Of the 1384 smokers randomized to the study, 20% were abstinent from smoking at 6 weeks and 8% were abstinent at 6 months.
View Article and Find Full Text PDFMinerva Cardioangiol
October 2002
Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic and Mayo Foundation Rochester, Minnesota, USA.
This article describes currently available intracardiac ultrasound (ICE) technology contrasting it with intravascular ultrasound (IVUS) highlighting their differences. Clinical applications in the electrophysiologic and cardiac catheterization laboratory are discussed and current limitations addressed. Intracardiac echocardiography (ICE) is possible because lower frequency transducers (in contrast to higher frequency IVUS devices) have been miniaturized and mounted onto catheters capable of percutaneous insertion into the heart.
View Article and Find Full Text PDFJ Clin Neuromuscul Dis
December 1999
From the *Department of Neurology, daggerDepartment of Dermarology, the double dagger Section of Biostatistics, and the Gonada Vascular Center, Mayo Clinic and Mayo foundation Rochester, MN.
Erythromelaigia is a poorly understood clinical syndrome characterized by painful, hot, red extremities. We assessed the frequency and types of abnormalities observed during tests of vascular, peripheral neurophysiologic, and autonomic function in patients with erythromelalgia.Methods Of" 163 charts of patients fulfilling the clinical diagnosis of erythromelalgia.
View Article and Find Full Text PDFAm Heart J
October 1999
Department of Internal Medicine, Mayo Clinic and Mayo Foundation. Rochester, MN, USA.
Background: We studied the histomorphometric correlates of long-term successful coronary balloon angioplasty (percutaneous transluminal coronary angioplasty [PTCA]). Restenosis after PTCA may occur secondary to the failure of compensatory arterial enlargement or post-PTCA arterial constriction. The histopathology of this process in human subjects remains poorly defined.
View Article and Find Full Text PDFJ Am Acad Dermatol
June 1998
Department of Dermatology, Mayo Clinic and Mayo Foundation Rochester, Minnesota 55905, USA.
Background: Urticarial vasculitis is characterized by persistent urticarial lesions with histologic evidence of leukocytoclastic vasculitis. Hypocomplementemic urticarial vasculitis (HUV) is a distinct clinical entity in a subset of patients with urticarial vasculitis.
Objective: We examined presentation of urticarial vasculitis and factors predictive of connective tissue disease.
Cancer
April 1980
Mayo Clinic and Mayo Foundation Rochester, Minnesota.
Central to the earlier detection and effective treatment of bladder cancer is the understanding of the basic principle that in situ cancer, evolving from epithelial atypia or hyperplasia, is the early phase in the development of invasive bladder cancer. While it may be asymptomatic, irritative bladder symptoms such as frequency, urgency, and dysuria irrespective of bacteriuria are usually evident and should be evaluated with exfoliative urinary cytology to detect the presence of this cancer. Properly collected and skillfully interpreted cytologic examination of the urine is probably the most accurate screening test for this and other important varieties of bladder cancer.
View Article and Find Full Text PDF